PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease ReportsAtrial flutter
MeSH D001282 - atrial flutter
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D001145:Cardiac arrhythmias
$
Success rate
D001282: 
Atrial flutter
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
TevaDiltiazem Diltiazem  1992-11-05   
Dofetilide Dofetilide  2022-04-15   
Metoprolol Metoprolol  1994-09-30   
Procainamide Procainamide  1982-01-01   
Sotalol Sotalol  2000-05-01   
Novast LaboratoriesDiltiazem Diltiazem  2019-06-14   
Dofetilide Dofetilide  2019-12-27   
Metoprolol Metoprolol  2018-02-06   
Glenmark PharmaceuticalsDiltiazem Diltiazem  2021-03-22   
MylanDiltiazem Diltiazem  1997-05-02   
Metoprolol Metoprolol  1993-12-21   
Hydrochlorothiazide, Metoprolol Metoprolol Hydrochlorothiazide  2004-08-20   
Rising PharmaceuticalsSotalol Sotalol  2000-12-19   
Digoxin Digoxin  1999-12-23   
Diltiazem Diltiazem  1992-11-05   
GSKDigoxin Lanoxicaps  1982-07-26   
CiplaMetoprolol Metoprolol  2018-10-26   
SandozDigoxin Digoxin  2003-08-21   
Diltiazem Diltiazem  2012-09-28   
Metoprolol Metoprolol  2006-07-31   
Procainamide Procainamide  1986-06-23   
Chartwell PharmaceuticalsDiltiazem Diltiazem  1992-11-05   
Metoprolol Metoprolol  1994-03-25   
1
2
3
4
5
6
...
13
>
Clinical Trials
Historical Success Rate
Phase 1
0%
0/0
Phase 2
50%
4/8
Phase 3
59%
20/34
Approved: 16Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Mylan
1
2
3
4
5
6
...
9
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use